Mount Yale Investment Advisors, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Mount Yale Investment Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$58.38 - $84.96 $154,415 - $224,719	-2,645 Closed	0 $0
Q2 2021 Aug 04, 2021	BUY	$62.15 - $90.32 $164,386 - $238,896	2,645 New	2,645 $219,000
Q1 2021 May 04, 2021	SELL	$61.35 - $90.47 $186,872 - $275,571	-3,046 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$43.82 - $85.37 $133,475 - $260,037	3,046 New	3,046 $234,000
Q4 2018 Feb 14, 2019	SELL	$10.74 - $19.7 $6,529 - $11,977	-608 Closed	0 $0

Q3 2018 Nov 13, 2018	BUY	$14.0 - $20.3 $8,512 - $12,342	608 New	608 $10,000

296

88.5M

905K

387K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Mount Yale Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mount Yale Investment Advisors, LLC with notifications on news.